Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whitewashing psychedelics: racial equity in the emerging field of psychedelic-assisted mental health research and treatment
Johannes Thrul, Albert Garcia‐Romeu
Drugs Education Prevention and Policy (2021) Vol. 28, Iss. 3, pp. 211-214
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey
Sandeep M. Nayak, Hillary Jackson, Nathan D. Sepeda, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 44
The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 16
The Need for Psychedelic-Assisted Therapy in the Black Community and the Burdens of Its Provision
Darron T. Smith, Sonya C. Faber, NiCole T. Buchanan, et al.
Frontiers in Psychiatry (2022) Vol. 12
Open Access | Times Cited: 44
Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry
Gregory Barber, Charles C. Dike
Psychiatric Services (2023) Vol. 74, Iss. 8, pp. 838-846
Closed Access | Times Cited: 37
How does psilocybin therapy work? An exploration of experiential avoidance as a putative mechanism of change
Richard J. Zeifman, Anne Catherine Wagner, Candice M. Monson, et al.
Journal of Affective Disorders (2023) Vol. 334, pp. 100-112
Open Access | Times Cited: 29
The Canadian Psychedelic Survey: Characteristics, Patterns of Use, and Access in a Large Sample of People Who Use Psychedelic Drugs
Stephanie Lake, Philippe Lucas
Psychedelic Medicine (2023) Vol. 1, Iss. 2, pp. 98-110
Closed Access | Times Cited: 19
Ethnoracial inclusion in clinical trials of psychedelics: a systematic review
Marcus Hughes, Albert Garcia‐Romeu
EClinicalMedicine (2024) Vol. 74, pp. 102711-102711
Open Access | Times Cited: 7
Ancient Roots of Today’s Emerging Renaissance in Psychedelic Medicine
Daniel R. George, Ryan Hanson, Darryl Wilkinson, et al.
Culture Medicine and Psychiatry (2021) Vol. 46, Iss. 4, pp. 890-903
Open Access | Times Cited: 33
The Emerging Field of Psychedelic Psychotherapy
Gregory Barber, Scott T. Aaronson
Current Psychiatry Reports (2022) Vol. 24, Iss. 10, pp. 583-590
Open Access | Times Cited: 26
Minorities’ diminished psychedelic returns: Cardio-metabolic health
Sean Matthew Viña
Drug Science Policy and Law (2024) Vol. 10
Open Access | Times Cited: 5
Experiential Training in Psychedelic‐Assisted Therapy: A Risk‐Benefit Analysis
Daniel Rosenbaum, Crystal Hare, Emma Hapke, et al.
The Hastings Center Report (2024) Vol. 54, Iss. 4, pp. 32-46
Open Access | Times Cited: 5
Enhanced independence: De-biasing processes in psychedelic research and beyond
Katherine Cheung, Rebecca Ehrenkranz, David B. Yaden
Research Ethics (2025)
Open Access
Minorities’ Diminished Psychedelic Returns: Income and Educations Impact on Whites, Blacks, Hispanics, and Asians
Sean M. Viña
Journal of Racial and Ethnic Health Disparities (2024)
Open Access | Times Cited: 4
Practical considerations in the establishment of psychedelic research programs
Brian S. Barnett, M. Frances Vest, Marcus S. Delatte, et al.
Psychopharmacology (2024)
Open Access | Times Cited: 4
Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 µg LSD in healthy participants within a novel intervention paradigm: A proof-of-concept study
Neiloufar Family, Peter S. Hendricks, Luke T. J. Williams, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 321-336
Open Access | Times Cited: 16
Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers
Sascha Thal, Liam Engel, Stephen Bright
Journal of Humanistic Psychology (2022)
Closed Access | Times Cited: 16
An Occupational Perspective on Psychedelic Therapy: A Scoping Review
Gabriella Ann Hogan, Karen Elaine Wagner, Erin Tichenor, et al.
Canadian Journal of Occupational Therapy (2024) Vol. 91, Iss. 3, pp. 272-287
Open Access | Times Cited: 3
Beating pain with psychedelics: Matter over mind?
Igor Elman, Amanda C. Pustilnik, David Borsook
Neuroscience & Biobehavioral Reviews (2021) Vol. 134, pp. 104482-104482
Closed Access | Times Cited: 21
Investigational drugs for assisting psychotherapy for posttraumatic stress disorder (PTSD): emerging approaches and shifting paradigms in the era of psychedelic medicine
Lynnette A. Averill, Chadi G. Abdallah
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 2, pp. 133-137
Open Access | Times Cited: 15
Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations
Cynthia E. Ortiz, Haley Maria Dourron, Noah W Sweat, et al.
Neuropharmacology (2022) Vol. 214, pp. 109127-109127
Open Access | Times Cited: 15
EMBARK Psychedelic Therapy for Depression
Bill Brennan, Alex Belser
(2024)
Closed Access | Times Cited: 2
Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. participants of Color: A longitudinal online survey study
Grant Jones, Matthew X. Lowe, Sandeep M. Nayak, et al.
Journal of Affective Disorders (2024)
Closed Access | Times Cited: 2
Functional imaging studies of acute administration of classic psychedelics, ketamine, and MDMA: Methodological limitations and convergent results
Sophia Linguiti, Jacob W. Vogel, Valerie J. Sydnor, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 154, pp. 105421-105421
Closed Access | Times Cited: 6
Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead
M.L. Williams, Diana Korevaar, Renee Harvey, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 15
Association between lifetime hallucinogen use and psychological distress varies by sexual identity in a nationally representative sample
B. M. Altman, Manya Magnus
Journal of Psychopharmacology (2024) Vol. 38, Iss. 10, pp. 861-872
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top